Home » ADVANCIS PHARMA POSTS NARROWER-THAN-EXPECTED LOSS FOR Q1
ADVANCIS PHARMA POSTS NARROWER-THAN-EXPECTED LOSS FOR Q1
Advancis Pharmaceutical Corp. reported net loss for the first quarter at $7.6 million, narrower than $11.4 million in the year-ago quarter. On a per share basis, loss for the current quarter narrowed to $0.25 from $0.50 in the same quarter last year. Analysts polled by First Call/Thomson Financial expected a loss of $0.29 per share. Trading Markets (http://www.tradingmarkets.com/tm.site/news/BREAKING%20NEWS/241716/)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May